Scarica l'app Stockscreener
28.31
3.42%
0.93
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CRNX Giù?
Forum
Previsione
Crinetics Pharmaceuticals Inc Borsa (CRNX) Ultime notizie
Crinetics Pharmaceuticals Announces August 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Crinetics Expands Team with 27 New Hires, Grants $2M+ in Equity Compensation Package - Stock Titan
Crinetics stock price target lowered to $86 by Citizens JMP on launch outlook - Investing.com Canada
Crinetics Pharmaceuticals Inc's Q2 2025 Earnings Call Highlights: Strategic Advancements, Financial Resilience Amid Rising Costs. - AInvest
Crinetics Pharmaceuticals' Q2 2025 Earnings: Financial Vulnerability and Clinical Dependencies Amid Pipeline Advancements - AInvest
Investors Might Be Losing Patience for Crinetics Pharmaceuticals' (NASDAQ:CRNX) Increasing Losses, as Stock Sheds 3.6% Over the Past Week - 富途牛牛
Crinetics Pharmaceuticals, Inc. (CRNX) Reports Q2 Loss, Lags Revenue Estimates - MSN
Crinetics Pharmaceuticals: A Pipeline-Driven Inflection Point in Endocrine Therapeutics - AInvest
Crinetics 2025 Q2 Earnings Widening Losses Despite Revenue Surge - AInvest
How to read the order book for Crinetics Pharmaceuticals Inc.Free AI Trading Suggestions With Accuracy Focus - Newser
Transcript : Crinetics Pharmaceuticals, Inc., Q2 2025 Earnings Call, Aug 07, 2025 - MarketScreener
Crinetics Pharmaceuticals (NASDAQ:CRNX) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance
Stifel lowers Crinetics stock price target to $58 from $60, keeps Buy rating - Investing.com Canada
Earnings call transcript: Crinetics Pharmaceuticals Q2 2025 results miss EPS forecast - Investing.com
Crinetics Pharmaceuticals Inc. (CRNX) Shares Soar 11.91% on 150% Revenue Surge - AInvest
Crinetics Pharmaceuticals Q2 Earnings: Revenue Rises, Shares Up - AInvest
Crinetics Pharmaceuticals Q2 Loss Widens, Revenue Rises; Shares up Pre-Bell - MarketScreener
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Shares Sold by Zurcher Kantonalbank Zurich Cantonalbank - Defense World
Crinetics Pharmaceuticals Inc (CRNX) Q2 2025 Earnings Call Highlights: Strategic Advancements ... By GuruFocus - Investing.com Canada
Crinetics Pharmaceuticals Inc (CRNX) Q2 2025 Earnings Call Highl - GuruFocus
Will breakout in Crinetics Pharmaceuticals Inc. lead to full recoveryRisk Adjusted Trade Signal Screening Tool - Newser
Decoding Crinetics Pharmaceuticals Inc (CRNX): A Strategic SWOT Insight - GuruFocus
Crinetics Pharmaceuticals: Promising Outlook with Anticipated Approval of Palsonify and Strategic Market Launch - TipRanks
Crinetics Pharmaceuticals Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Crinetics reports Q2 EPS ($1.23), consensus ($1.10) - TipRanks
Why Crinetics Pharmaceuticals Inc. stock attracts strong analyst attentionSmart Risk Entry Zone Technical Analysis - Newser
Crinetics Pharma earnings missed by $0.13, revenue topped estimates - Investing.com Canada
Crinetics Q2: $1.2B cash, PDUFA date for PALSONIFY, atumelnant progress. - AInvest
Crinetics Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update | CRNX Stock News - GuruFocus
Crinetics Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update - The Manila Times
Crinetics Earnings: $1.2B War Chest Powers PALSONIFY Launch, FDA Decision Looms in September - Stock Titan
Crinetics Pharmaceuticals Q2 2025 Earnings Call Transcript - MarketBeat
Crinetics CRNX Q2 2025 Earnings Preview Downside Expected on Analyst EPS Downgrades - AInvest
Crinetics Pharmaceuticals, Inc. (CRNX)’ Oral Acromegaly Drug Nears FDA Decision After Strong Phase 3 Data - MSN
What are the technical indicators suggesting about Crinetics Pharmaceuticals Inc.Dynamic investment growth - Jammu Links News
Is it the right time to buy Crinetics Pharmaceuticals Inc. stockFastest-growing stock picks - Jammu Links News
What are analysts’ price targets for Crinetics Pharmaceuticals Inc. in the next 12 monthsStay informed with daily expert analysis - Jammu Links News
What institutional investors are buying Crinetics Pharmaceuticals Inc. stockFree Stock Movement Tracking - Jammu Links News
What is the risk reward ratio of investing in Crinetics Pharmaceuticals Inc. stockOver 200% growth - Jammu Links News
How strong is Crinetics Pharmaceuticals Inc. company’s balance sheetGet timely market insights for better trades - Jammu Links News
Real time alert setup for Crinetics Pharmaceuticals Inc. performanceConsistent Gain Plan with AI Support - Newser
When is Crinetics Pharmaceuticals Inc. stock expected to show significant growthInvest smarter with daily trading signals - Jammu Links News
Does Crinetics Pharmaceuticals Inc. stock perform well during market downturnsGet daily updates on market movers and shakers - Jammu Links News
Fibonacci Support Holding Strong in Crinetics Pharmaceuticals Inc.Trade Timing Strategy With Technical Data Explained - metal.it
Are Bears Losing Grip on Crinetics Pharmaceuticals Inc.Real Time Trade Opportunity Alerts Monitor Market Surges - metal.it
Earnings Preview: Crinetics Pharmaceuticals, Inc. (CRNX) Q2 Earnings Expected to Decline - Yahoo Finance
11 Best Future Stocks to Buy Now - Insider Monkey
What makes Crinetics Pharmaceuticals Inc. stock price move sharplyCapital Preserving Trade Plan Templates Shared - metal.it
Can Crinetics Pharmaceuticals Inc. Bounce Back From Weekly LowSmart Investment Tips Gaining Popularity Among Analysts - metal.it
Analyzing net buyer seller activity in Crinetics Pharmaceuticals Inc.Steady Return Plan Based on Data Analysis - Newser
Using data filters to optimize entry into Crinetics Pharmaceuticals Inc.Technical Screener for High Growth Stocks - Newser
Pattern recognition hints at Crinetics Pharmaceuticals Inc. upsideConsistent Return Setup with Exit Strategy - Newser
How does Crinetics Pharmaceuticals Inc. compare to its industry peersInvest confidently with proven investment plans - Jammu Links News
Should I hold or sell Crinetics Pharmaceuticals Inc. stock in 2025Best Dividend Updates For Beginners - jammulinksnews.com
0.43%
6.87%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):